本文選題：膀胱癌　切入點(diǎn)：wnt信號(hào)　出處：《內(nèi)蒙古大學(xué)》2017年碩士論文　論文類(lèi)型：學(xué)位論文

【摘要】：目的:檢測(cè)WIF1在膀胱癌組織與血清中的表達(dá)水平,并分析其與MMP-9的相關(guān)性,探討其在膀胱癌的發(fā)生發(fā)展中的調(diào)節(jié)機(jī)制。方法:1、收集病例,分為實(shí)驗(yàn)組與對(duì)照組,實(shí)驗(yàn)組為膀胱癌組織,對(duì)照組為膀胱癌旁正常組織;實(shí)驗(yàn)組被分為高分化組與低分化組及浸潤(rùn)組與非浸潤(rùn)組。2、Real-time PCR檢測(cè)WIF1在膀胱癌組織與癌旁正常組織、高分化組與低分化組、浸潤(rùn)組與非浸潤(rùn)組的基因表達(dá)。4、ELISA檢測(cè)WIF1在膀胱癌高分化組與低分化組、浸潤(rùn)組與非浸潤(rùn)組血清蛋白表達(dá)。5、分別檢測(cè)WIF1與MMP-9在膀胱癌浸潤(rùn)組的血清蛋白含量,分析二者的相關(guān)性。結(jié)果:1、在實(shí)驗(yàn)組與癌旁對(duì)照組檢測(cè)WIF1基因表達(dá)水平顯示,實(shí)驗(yàn)組的基因表達(dá)量(0.23 ±0.131)明顯低于癌旁對(duì)照組(0.54±0.170),差異具有統(tǒng)計(jì)學(xué)意義(t=-0.710、P0.001);在低分化組WIF1基因表達(dá)量(0.16 ± 0.082)明顯低于高分化組(0.26±0.088),差異具有統(tǒng)計(jì)學(xué)意義(t=-3.135、P0.01);在浸潤(rùn)組WIF1基因表達(dá)量(0.14±0.087)明顯低于非浸潤(rùn)組(0.28±0.135),差異具有統(tǒng)計(jì)學(xué)意義(t=-3.204、P0.01)。2、WIF1在血清中蛋白表達(dá)檢測(cè)顯示,在低分化組的表達(dá)水平(21.85±5.833)明顯低于高分化組(30.35±8.040),差異具有統(tǒng)計(jì)學(xué)意義(t=-3.203、P0.01);WIF1蛋白在浸潤(rùn)組的表達(dá)量(21.56±5.141)明顯低于非浸潤(rùn)組(31.97土9.064),差異具有統(tǒng)計(jì)學(xué)意義(t=-3.599、P0.01);在浸潤(rùn)組,WIF1蛋白的表達(dá)與MMP-9蛋白表達(dá)具有相關(guān)性,呈負(fù)相關(guān)(r=-0.643、p0.05)。結(jié)論:1.WIF1與膀胱癌的發(fā)生、侵襲浸潤(rùn)密切相關(guān),其在膀胱癌的發(fā)生、侵襲浸潤(rùn)中可能發(fā)揮重要調(diào)節(jié)功能,可能是通過(guò)調(diào)節(jié)經(jīng)典wnt信號(hào)通路發(fā)揮作用。2.WIF1在血清中的異常表達(dá)可能為臨床的早期發(fā)現(xiàn)提供有效證據(jù),可能為膀胱癌的病理分級(jí)、侵襲浸潤(rùn)能力及術(shù)后預(yù)后的判斷提供簡(jiǎn)單有效的檢測(cè)方法。3.在膀胱癌的侵襲浸潤(rùn)中,WIF1可能通過(guò)促進(jìn)MMP-9的表達(dá)進(jìn)而發(fā)揮其侵襲浸潤(rùn)功能,其可能通過(guò)激活經(jīng)典wnt信號(hào)通路發(fā)揮作用,或二者之間存在獨(dú)立信號(hào)機(jī)制。
[Abstract]:Objective: to detect the expression of WIF1 in bladder cancer tissues and serum, and to analyze its correlation with MMP-9, and to explore its regulatory mechanism in the occurrence and development of bladder cancer. Methods: one case was collected and divided into experimental group and control group. The experimental group was divided into high differentiation group and low differentiation group, and infiltration group and non-invasive group. Real-time PCR was used to detect WIF1 in bladder cancer tissue and adjacent normal tissue, high differentiation group and low differentiation group. The expression of WIF1 was detected by Elisa in high differentiation and low differentiation groups, infiltration group and non invasive group. The serum protein levels of WIF1 and MMP-9 in bladder cancer infiltrating group were detected respectively. Results: the expression level of WIF1 gene was detected in the experimental group and the adjacent control group. The expression of WIF1 gene in the experimental group (0.23 鹵0.131) was significantly lower than that in the control group (0.54 鹵0.170), the difference was statistically significant, and the expression of WIF1 gene in the poorly differentiated group (0.16 鹵0.082) was significantly lower than that in the well-differentiated group (0.26 鹵0.088). The expression level of WIF1 in serum was significantly lower than that in non-invasive group (0.14 鹵0.087), and the difference was statistically significant. The expression level of WIF1 protein in the poorly differentiated group (21.85 鹵5.833) was significantly lower than that in the well-differentiated group (30.35 鹵8.040), the difference was statistically significant (P < 21.56 鹵5.141), and the expression of WIF1 protein in the infiltrating group was significantly lower than that in the non-invasive group (31.97 鹵9.064), the difference was statistically significant (P 0.01), and the expression of WIF1 protein in the infiltrating group was significantly lower than that in the non-invasive group. The expression of MMP-9 was correlated with the expression of MMP-9 protein. Conclusion: 1. WIF1 is closely related to the occurrence and invasion of bladder cancer, which may play an important regulatory role in the occurrence and invasion of bladder cancer. The abnormal expression of WIF1 in serum may provide effective evidence for early clinical discovery and may be the pathological grade of bladder cancer. Evaluation of invasive invasion ability and postoperative prognosis provides a simple and effective method for detecting invasion and invasion of bladder cancer. WIF1 may play an invasive and invasive function by promoting the expression of MMP-9 in bladder cancer invasion and invasion. It may play a role by activating the classical wnt signaling pathway, or there is an independent signal mechanism between the two.
【學(xué)位授予單位】：內(nèi)蒙古大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類(lèi)號(hào)】：R737.14

【參考文獻(xiàn)】

相關(guān)博士學(xué)位論文 前1條

1 孫陽(yáng);組蛋白去乙酰化酶抑制劑抑制膀胱尿路上皮癌作用機(jī)制的研究[D];復(fù)旦大學(xué);2012年

，

本文編號(hào)：1598724